Clinical Trial: D-TECT: Pretreatment D-dimers and Disease Control in Advanced cSCC Treated With Cemiplimab

U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07684066) titled 'D-TECT: Pretreatment D-dimers and Disease Control in Advanced cSCC Treated With Cemiplimab' on June 28.

Brief Summary: D-TECT is a prospective, multicenter, non-interventional observational study investigating whether pretreatment D-dimer levels predict disease control in patients with locally advanced or metastatic cutaneous squamous cell carcinoma treated with cemiplimab in routine clinical care.

D-dimers are routinely available laboratory markers related to activation of the coagulation system. Previous single-center data suggest that elevated pretreatment D-dimer levels may be associated with poorer disease control under cemipli...